{
    "doi": "https://doi.org/10.1182/blood-2021-147359",
    "article_title": "Haploidentical Peripheral Blood Stem Cell Transplantation (Haplo-PBSCT) with Cyclophosphamide Pos Transplant (CyPost) in High-Risk Hematologic Malignancies. Results of 5 Years in Transplant Center in Northeast of Mexico ",
    "article_date": "November 5, 2021",
    "session_type": "721.Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities",
    "abstract_text": "Introduction : Haploidentical peripheral blood stem cell transplantation ( Haplo-PBSCT) is a curative option in patient with hematology malignancy. In Mexico is very difficult to find an identical HLA donor , for this reason Haplo PBSCT it is an option in our public Health institution. Materials and methods : we aimed a retrospective study since (2017 -2021) in our Hospital Unidad M\u00e9dica de alta Especialidad 25, Instituto Mexicano del Seguro Social (IMSS UMAE 25) Monterrey, Mexico. We include patients over 15 years of age who were undergo Haplo PBSCT with hematolgy malignancies . We performed Analysis of Overall and Relapse-free survival with kaplan meier curves and incidence of acute and chronic graft versus host disease (GVHD) and percentage of Transplant-Related Mortality (TRM). Results : we analized a 38 patients, the median age was 35 years (range 15-64). Of the total , 25 were male (65%) and 13 famale (34%). The rest of baseline data is described in table 1. The median time of neutrophil engrafment was days 17 ( 11-26 ) and platelets was 19.5 days ( 12-38 ). The Incidence of Primary Graft failure was 18 % ( seven patients). Patients with graft had 99-100% chimerism at day 100. The Incidence of aGVHD was 26 % and the cGVHD was 16%. DLI was used in four patients to treat passenger lymphocyte syndrome (2 patients) and ( 2 patients) with severe graft rejection. The principal cause of death was sepsis in eleven patients (29%). Two patients with acute leukemia (AML and ALL) died after development of post transplant lymphoproliferative disease. The TRM was 28.2%. There were no relapse-related deaths during follow-up after Haplo-PBSCT. The median of survival was 4.5 months ( range 1-44) with Overall Survival (OS) of 42 % at 3 years ( figure 1). Conclusion : Our analysis shows results that were comparable with those published in first world international transplant centers . Relapse remains the major cause of transplant failure, in our population the antigenic disparity between donor and recipient can strengthen the immune response versus disease. Haplo-PBSCT is a feasible transplantation method in patients with hematological malignancies in developing countries with limited resources. Figure 1 View large Download slide Figure 1 View large Download slide  Close modal Disclosures No relevant conflicts of interest to declare.",
    "author_names": [
        "Severiano Baltazar",
        "Myrna Patricia Peque\u00f1o Luevano",
        "Guadalupe Gonz\u00e1lez Villarreal",
        "Guillermo Sotomayor Duque",
        "Raul Ramos Vazquez",
        "Diego Cruz Contreras",
        "Martha Lilia Guajardo Leal",
        "Helga Patricia Sorkee Davila",
        "Jose Alfredo Carrizalez Villarreal",
        "Jose Luis Cedillo",
        "Alba Nydia Ramirez L\u00f3pez",
        "Isabel Borjon Cabada",
        "Christian Quirino Marquez",
        "Arantxa Mecott Estudillo",
        "Gerardo Avila Contreras",
        "Willy Nava Guti\u00e9rrez",
        "Dora Aldama Guti\u00e9rrez",
        "Juan Daniel Garza Escobar",
        "Yarezi Garcia Cerda",
        "Victor Valerio Bugarin",
        "Karen Machuca Adame",
        "Luis Omar Gudi\u00f1o Cobos",
        "Rosa Elva De Leon Cantu",
        "Roberto Hernadez Valdez"
    ],
    "author_dict_list": [
        {
            "author_name": "Severiano Baltazar",
            "author_affiliations": [
                "Hematopoietic stem cell Unit IMSS UMAE 25, IMSS UMAE 25, Mexico City, MEX"
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Myrna Patricia Peque\u00f1o Luevano",
            "author_affiliations": [
                "Hematopoietic stem cell Unit IMSS UMAE 25, IMSS UMAE 25, Monterrey, MEX"
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Guadalupe Gonz\u00e1lez Villarreal",
            "author_affiliations": [
                "Hematopoietic stem cell Unit IMSS UMAE 25, IMSS UMAE 25, Monterrey, Mexico"
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Guillermo Sotomayor Duque",
            "author_affiliations": [
                "IMSS UMAE 25, Monterrey, Mexico"
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Raul Ramos Vazquez",
            "author_affiliations": [
                "Cryopreservation Unit, IMSS UMAE 25, Monterrey, Mexico"
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Diego Cruz Contreras",
            "author_affiliations": [
                "HEMATOLOGIA, INSTITUTO MEXICANO DEL SEGURO SOCIAL, MONTERREY, MEX"
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Martha Lilia Guajardo Leal",
            "author_affiliations": [
                "IMSS UMAE 25, Monterrey, Mexico"
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Helga Patricia Sorkee Davila",
            "author_affiliations": [
                "IMSS UMAE 25, Monterrey, Mexico"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jose Alfredo Carrizalez Villarreal",
            "author_affiliations": [
                "HEMATOLOGO, INSTITUTO MEXICANO DEL SEGURO SOCIAL, MONTERREY, Mexico"
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jose Luis Cedillo",
            "author_affiliations": [
                "IMSS UMAE 25, Mexico, MEX"
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alba Nydia Ramirez L\u00f3pez",
            "author_affiliations": [
                "HEMATOLOGA, INSTITUTO MEXICANO DEL SEGURO SOCIAL, Monterrey, MEX"
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Isabel Borjon Cabada",
            "author_affiliations": [
                "IMSS UMAE 25, Monterrey, MEX"
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Christian Quirino Marquez",
            "author_affiliations": [
                "IMSS UMAE 25, Monterrey, Mexico"
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Arantxa Mecott Estudillo",
            "author_affiliations": [
                "IMSS UMAE 25, Monterrey, Mexico"
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gerardo Avila Contreras",
            "author_affiliations": [
                "IMSS UMAE 25, Monterrey, Mexico"
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Willy Nava Guti\u00e9rrez",
            "author_affiliations": [
                "IMSS UMAE 25, Monterrey, Mexico"
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Dora Aldama Guti\u00e9rrez",
            "author_affiliations": [
                "IMSS UMAE 25, Monterrey, Mexico"
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Juan Daniel Garza Escobar",
            "author_affiliations": [
                "IMSS UMAE 25, Monterrey, Mexico"
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Yarezi Garcia Cerda",
            "author_affiliations": [
                "IMSS UMAE 25, Monterrey, Mexico"
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Victor Valerio Bugarin",
            "author_affiliations": [
                "IMSS UMAE 25, Monterrey, Mexico"
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Karen Machuca Adame",
            "author_affiliations": [
                "IMSS UMAE 25, Monterrey, Mexico"
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Luis Omar Gudi\u00f1o Cobos",
            "author_affiliations": [
                "IMSS UMAE 25, Monterrey, Mexico"
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Rosa Elva De Leon Cantu",
            "author_affiliations": [
                "Chief of Hematology, IMSS UMAE 25, Monterrey, Mexico"
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Roberto Hernadez Valdez",
            "author_affiliations": [
                "Chief of Hematology-Oncology Division, IMSS UMAE 25, Monterrey, Mexico"
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-21T18:38:29",
    "is_scraped": "1"
}